Anti C5 Complement mAb Placebo, Ultomiris 300 mg/30 mL concentrate for solution for infusion
ALXN1210-TMA-313
Phase 3 small_molecule active
Quick answer
Anti C5 Complement mAb Placebo, Ultomiris 300 mg/30 mL concentrate for solution for infusion for Hematopoietic stem cell transplant-associated thrombotic microangiopathy is a Phase 3 program (small_molecule) at Alexion Europe SAS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Alexion Europe SAS
- Indication
- Hematopoietic stem cell transplant-associated thrombotic microangiopathy
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active